{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:09:40Z","timestamp":1780513780077,"version":"3.54.1"},"reference-count":44,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Splenic artery embolization (SAE) is commonly used in cirrhosis to manage hypersplenism and cytopenia. However, its longer-term clinical impact beyond hematologic parameters remains insufficiently characterized. Aim: To characterize longitudinal inpatient trajectories, clinical patterns, and follow-up features after SAE in patients with cirrhosis treated at a tertiary referral center in Kazakhstan. Methods: This retrospective single-center study included 149 patients with cirrhosis who underwent SAE. Clinical, laboratory, and imaging data were collected across sequential inpatient episodes. Outcomes included longitudinal patterns of hospitalization, laboratory trends, and baseline factors associated with a favorable clinical course. Subsequent hospitalization was defined as any inpatient episode following the index SAE admission, regardless of whether it was planned or unplanned. Results: During follow-up, 59.1% of patients had a second inpatient episode, with progressively fewer patients contributing to later observations. Liver disease severity remained largely stable, with no significant changes in Child\u2013Pugh distribution. Portal hypertension manifestations, including varices and splenomegaly, remained highly prevalent, while recurrent variceal bleeding was relatively uncommon. Laboratory parameters demonstrated modest changes without sustained statistically significant improvement, and the number of recorded inpatient episodes decreased across sequential follow-up. Relatively stable documented follow-up trajectories were more frequently observed in patients with preserved liver function (Child\u2013Pugh A), absence of ascites, and higher albumin levels. The most common causes of subsequent hospitalization were ascites and hepatic decompensation (38.9%) and varices without bleeding (26.2%), while documented major procedure-related complications were infrequent. Conclusions: In this retrospective single-center cohort, predominantly coil-based proximal or selective SAE demonstrated an acceptable documented major complication profile in selected patients with cirrhosis and portal hypertension. Because no untreated control group was available, the findings should be interpreted as descriptive real-world longitudinal data rather than causal evidence of reduced hospitalization burden.<\/jats:p>","DOI":"10.3390\/jcm15114337","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:08:07Z","timestamp":1780510087000},"page":"4337","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal Inpatient Trajectories After Splenic Artery Embolization in Cirrhosis: Real-World Evidence from Kazakhstan"],"prefix":"10.3390","volume":"15","author":[{"given":"Ainur","family":"Doszhan","sequence":"first","affiliation":[{"name":"JSC National Scientific Medical Center, 010009 Astana, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niyaz","family":"Malayev","sequence":"additional","affiliation":[{"name":"JSC National Scientific Medical Center, 010009 Astana, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abai","family":"Baigenzhin","sequence":"additional","affiliation":[{"name":"JSC National Scientific Medical Center, 010009 Astana, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Tostanovskaya","sequence":"additional","affiliation":[{"name":"JSC National Scientific Medical Center, 010009 Astana, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0954-896X","authenticated-orcid":false,"given":"Anuar","family":"Abdikarimov","sequence":"additional","affiliation":[{"name":"JSC National Scientific Medical Center, 010009 Astana, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9012-0450","authenticated-orcid":false,"given":"Kristina","family":"Pavlova","sequence":"additional","affiliation":[{"name":"JSC National Scientific Medical Center, 010009 Astana, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assyltay","family":"Nauryzbayeva","sequence":"additional","affiliation":[{"name":"JSC National Scientific Medical Center, 010009 Astana, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balzhan","family":"Abzhaparova","sequence":"additional","affiliation":[{"name":"National Scientific Center of Surgery Named After A.N. Syzganov, 050004 Almaty, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulsara","family":"Imambaeva","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine No. 2, Astana Medical University, 010000 Astana, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global Epidemiology of Cirrhosis\u2014Aetiology, Trends and Predictions","volume":"20","author":"Huang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e0026","DOI":"10.1097\/HC9.0000000000000026","article-title":"The Burden of Liver Cirrhosis and Underlying Etiologies: Results from the Global Burden of Disease Study 2019","volume":"7","author":"Lan","year":"2023","journal-title":"Hepatol. Commun."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.3748\/wjg.v28.i41.5910","article-title":"Epidemiology of Liver Cirrhosis and Associated Complications: Current Knowledge and Future Directions","volume":"28","author":"Liu","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S2468-1253(22)00386-7","article-title":"Global Reporting of Progress towards Elimination of Hepatitis B and Hepatitis C","volume":"8","author":"Cui","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S2468-1253(22)00050-4","article-title":"Worldwide Prevalence of Hepatitis B Virus and Hepatitis C Virus among Patients with Cirrhosis at Country, Region, and Global Levels: A Systematic Review","volume":"7","author":"Alberts","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Staufer, K., and Stauber, R.E. (2023). Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?. Biomedicines, 11.","DOI":"10.3390\/biomedicines11082108"},{"key":"ref_7","first-page":"35","article-title":"Epidemiology of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Alcohol-Related Liver Disease (ALD)","volume":"4","author":"Wong","year":"2024","journal-title":"Metab. Target Organ Damage"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5009\/gnl230072","article-title":"Recent Advances in the Pathogenesis and Clinical Evaluation of Portal Hypertension in Chronic Liver Disease","volume":"18","author":"Kotani","year":"2024","journal-title":"Gut Liver"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Jagdish, R.K., Roy, A., Kumar, K., Premkumar, M., Sharma, M., Rao, P.N., Reddy, D.N., and Kulkarni, A.V. (2023). Pathophysiology and Management of Liver Cirrhosis: From Portal Hypertension to Acute-on-Chronic Liver Failure. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1060073"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Porada, M., and Bu\u0142dak, \u0141. (2025). From Pathophysiology to Practice: Evolving Pharmacological Therapies, Clinical Complications, and Pharmacogenetic Considerations in Portal Hypertension. Metabolites, 15.","DOI":"10.3390\/metabo15020072"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1080\/00365521.2023.2175619","article-title":"Decompensation as Initial Presentation in Patients with Liver Cirrhosis Is Associated with an Increased Risk of Future Decompensation and Mortality","volume":"58","author":"Kuipers","year":"2023","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/ueg2.70077","article-title":"Burden of Alcohol-Related Liver Disease and Alcohol Use Disorder in Asia","volume":"13","author":"Danpanichkul","year":"2025","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"9304","DOI":"10.1038\/s41598-024-60086-7","article-title":"Evaluation of Liver Transplantation Services in Kazakhstan from 2012 to 2023","volume":"14","author":"Semenova","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.2147\/IDR.S363609","article-title":"Epidemiological Characteristics of Chronic Viral Hepatitis in Kazakhstan: Data from Unified Nationwide Electronic Healthcare System 2014\u20132019","volume":"15","author":"Ashimkhanova","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3748\/wjg.v30.i4.290","article-title":"Portal Hypertension in Patients with Nonalcoholic Fatty Liver Disease: Current Knowledge and Challenges","volume":"30","author":"Madir","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"ref_16","first-page":"380","article-title":"Understanding Clinically Significant Portal Hypertension: An In-Depth Look at Pathogenesis, Diagnosis and Treatment","volume":"38","author":"Vanderschueren","year":"2025","journal-title":"Ann. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"de Sousa, R.N., and Nery, F.G. (2025). Splenomegaly and Hypersplenism in Liver Cirrhosis. Recent Advances in Liver Cirrhosis Related Complications, Academic Press.","DOI":"10.1016\/B978-0-443-21938-2.00013-8"},{"key":"ref_18","first-page":"e27718","article-title":"A Comprehensive Review of Thrombocytopenia with a Spotlight on Intensive Care Patients","volume":"14","author":"Santoshi","year":"2022","journal-title":"Cureus"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Fadlallah, H., El Masri, D., Bahmad, H.F., Abou-Kheir, W., and El Masri, J. (2025). Update on the Complications and Management of Liver Cirrhosis. Med. Sci., 13.","DOI":"10.3390\/medsci13010013"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/17474086.2022.2144217","article-title":"Rational Hemostatic Management in Cirrhosis: From Old Paradigms to New Clinical Challenges","volume":"15","author":"Bitto","year":"2022","journal-title":"Expert Rev. Hematol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1111\/ans.18633","article-title":"Risk Factors of Portal Vein System Thrombosis after Splenectomy: A Meta-Analysis","volume":"93","author":"Lin","year":"2023","journal-title":"ANZ J. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"102597","DOI":"10.1016\/j.jceh.2025.102597","article-title":"Proximal Splenic Artery Embolization: A Promising and Potential Tool","volume":"15","author":"Mukund","year":"2025","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Srivastava, A., Mukund, A., Baby, A., Patidar, Y., Jindal, A., and Sarin, S. (2026). Partial Splenic Embolization in Patients with Cirrhosis: Comparison of <50% versus >50% Infarction Strategy. Indian J. Gastroenterol., Advance online publication.","DOI":"10.1007\/s12664-025-01921-1"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Zhao, K., Hu, H.T., Li, H.L., Cheng, H.T., Zhao, Y.N., Hang, Y., and Yao, Q.J. (2025). Analysis of the Efficacy of Splenic Artery Superselective Embolization in Cirrhosis with Hepatocellular Carcinoma. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0323829"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Yue, B., Yang, D., Lu, Z., Zhao, S., and Tang, Z. (2025). Partial Splenic Embolization Combined with Endoscopic Variceal Ligation in Variceal Rebleeding Prevention among Liver Cirrhosis Patients Complicated with Hypersplenism, Thrombocytopenia, and Esophagogastric Variceal Hemorrhage: A Prospective Observational Study. BMC Gastroenterol., 25.","DOI":"10.1186\/s12876-025-04329-5"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/13645706.2023.2275652","article-title":"Perioperative Proximal Splenic Artery Embolization in Cirrhotic Patients with Splenomegaly","volume":"33","author":"Mitani","year":"2024","journal-title":"Minim. Invasive Ther. Allied Technol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1515\/med-2022-0479","article-title":"Repeated Partial Splenic Artery Embolization for Hypersplenism Improves Platelet Count","volume":"17","author":"Tan","year":"2022","journal-title":"Open Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.21037\/atm-20-1762","article-title":"Incidence and Predictors of 30-Day Hospital Readmissions for Liver Cirrhosis: Insights from the United States National Readmissions Database","volume":"9","author":"Garg","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"03000605231223087","DOI":"10.1177\/03000605231223087","article-title":"Risk Factors for Hospital Readmission among Patients with Cirrhosis and Ascites in China: A Retrospective Observational Study","volume":"52","author":"Li","year":"2024","journal-title":"J. Int. Med. Res."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Battle, A., Mudd, J., Ahlenstiel, G., and Kalo, E. (2025). Liver Cirrhosis: Evolving Definitions, and Recent Advances in Diagnosis, Prevention and Management. Livers, 5.","DOI":"10.3390\/livers5030028"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s10620-019-05826-w","article-title":"Predicting 30-Day Hospital Readmission Risk in a National Cohort of Patients with Cirrhosis","volume":"65","author":"Koola","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e00584","DOI":"10.14309\/ctg.0000000000000584","article-title":"Prevalence of Sarcopenia in Liver Cirrhosis: A Systematic Review and Meta-Analysis","volume":"14","author":"Mazeaud","year":"2023","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Saeki, M., Okubo, H., Takasaki, Y., Nakadera, E., Fukuo, Y., Fukada, H., Hotchi, Y., Maruyama, H., Kokubu, S., and Shiina, S. (2023). The Impact of Partial Splenic Embolization on Portal Hypertensive Gastropathy in Cirrhotic Patients with Portal Hypertension. J. Clin. Med., 12.","DOI":"10.3390\/jcm12072662"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Nesci, A., Ruggieri, V., Manilla, V., Spinelli, I., Santoro, L., Di Giorgio, A., Santoliquido, A., and Ponziani, F.R. (2024). Endothelial Dysfunction and Liver Cirrhosis: Unraveling of a Complex Relationship. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252312859"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/gutjnl-2019-318237","article-title":"Cirrhosis as New Indication for Statins","volume":"69","author":"Bosch","year":"2020","journal-title":"Gut"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Ichim, C., Boicean, A., Todor, S.B., Anderco, P., and B\u00eerlu\u021biu, V. (2025). Fecal Microbiota Transplantation in Patients with Alcohol-Associated Cirrhosis: A Clinical Trial. J. Clin. Med., 14.","DOI":"10.3390\/jcm14175981"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII\u2014Renewing Consensus in Portal Hypertension","volume":"76","author":"Bosch","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.avsg.2022.09.055","article-title":"Long-Term Effects of Proximal Splenic Artery Embolization on Splenic Volume and Platelet Count","volume":"89","author":"Bhatia","year":"2023","journal-title":"Ann. Vasc. Surg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e30985","DOI":"10.1097\/MD.0000000000030985","article-title":"Analysis of Predictors after Partial Splenic Embolization for Thrombocytopenia with Liver Cirrhosis","volume":"101","author":"Ishikawa","year":"2022","journal-title":"Medicine"},{"key":"ref_40","first-page":"e65319","article-title":"Exploring Haematological Complications in Cirrhosis of the Liver: A Comprehensive Review","volume":"16","author":"Tantia","year":"2024","journal-title":"Cureus"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/HEP.0000000000000647","article-title":"AASLD Practice Guidance on Risk Stratification and Management of Portal Hypertension and Varices in Cirrhosis","volume":"79","author":"Kaplan","year":"2024","journal-title":"Hepatology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/flgastro-2023-102431","article-title":"British Society of Gastroenterology Best Practice Guidance: Outpatient Management of Cirrhosis\u2014Part 2: Decompensated Cirrhosis","volume":"14","author":"Mansour","year":"2023","journal-title":"Frontline Gastroenterol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"104761","DOI":"10.4254\/wjh.v17.i6.104761","article-title":"Advances in the Diagnosis and Management of Clinically Significant Portal Hypertension in Cirrhosis: A Narrative Review","volume":"17","author":"Xie","year":"2025","journal-title":"World J. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2024). EASL Clinical Practice Guidelines on Genetic Cholestatic Liver Diseases. J. Hepatol., 81, 303\u2013325.","DOI":"10.1016\/j.jhep.2024.04.006"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/11\/4337\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:30:18Z","timestamp":1780511418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/11\/4337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":44,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jcm15114337"],"URL":"https:\/\/doi.org\/10.3390\/jcm15114337","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]}}}